Diagnostic Innovation

Boston, Aug. 10, 2026 Elicio Therapeutics, Inc. announced the activation of an investigator-initiated Phase 1 clinical study evaluating its...

Miami, August 10, 2026 Telomir Pharmaceuticals, Inc. announced the peer-reviewed publication of preclinical data showing that Telomir-Zn suppressed tumor...

Waltham, Mass., August 10, 2026 Revvity, Inc. announced the launch of its SuperFlex™ prenatal screening system, a compact, CE-IVDR...

SARASOTA, Fla., July 22, 2026 Lakewood-Amedex Biotherapeutics Inc. has announced new preclinical resistance data supporting its lead antimicrobial candidate...

SALT LAKE CITY, July 22, 2026 Co-Diagnostics, Inc. has announced that its Indian joint venture, CoSara Diagnostics Pvt. Ltd.,...

LAWRENCEVILLE, N.J., July 21, 2026 IMUNON, Inc. has announced positive preliminary Phase 2 minimal residual disease (MRD) clinical data...

SALT LAKE CITY, Utah, July 21, 2026 Myriad Genetics has officially launched the FirstGene® Multiple Prenatal Screen, introducing what...

IRVINE, Calif., July 15, 2026 Zepto Life Technology has expanded its FungiFlex® molecular diagnostics portfolio with the launch of...

BOULDER, Colo., June 16, 2026 Edgewise Therapeutics has announced positive top-line results from the 12-week Phase 2 CIRRUS-HCM trial...

FRIENDSWOOD, Texas, June 16, 2026 Castle Biosciences has announced that its TissueCypher® Barrett’s Esophagus Test has surpassed 100,000 clinical...